

For the last 5 years, STALLERGENES has experienced sustained dynamic activity reflected by an increase of nearly 45% in its workforce, with the acquisition in 2005 of IPI pharmaceutical company in Spain and Portugal.
This development mainly concerns the recruitment of managers. It has allowed for the reinforcement of the scientific teams (+47% in 3 years) and sales force (+60% in 3 years) in both the existing and newly created subsidiaries.
An overall increase in the level of qualification of the workforce makes it possible to support both dynamic growth and the Group’s objectives in an environment that is becoming more and more complex.
The training policy is an important factor for personal and professional development. In this way the Group enables its employees to adapt to the changes in occupations and in the pharmaceutical environment.
Learn more…